US Stock MarketDetailed Quotes

NLSP NLS Pharmaceutics

Watchlist
  • 2.1100
  • -0.6100-22.43%
Close Dec 31 16:00 ET
  • 2.0200
  • -0.0900-4.27%
Post 19:56 ET
5.82MMarket Cap-0.31P/E (TTM)

NLS Pharmaceutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NLS Pharmaceutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--
--------
--------

Unlock Free Earnings Estimates

NLS Pharmaceutics Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 4, 2024 16:17 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 15, 2024 17:03 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 12, 2024 16:06 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 5, 2024 08:01 ET

    • Read more

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data